Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Dupixent Pen

Dupilumab

Open in the dashboard

Part D claims

390,688

Prescriptions dispensed, refills included

Drug cost

$1,547,122,325

Paid at the pharmacy, in all

Prescribers

13,112

With 11 or more claims of it

In 2024, Medicare Part D recorded 390,688 claims for Dupixent Pen (dupilumab) from 13,112 prescribers, at a total drug cost of $1.5 billion paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 52 states and territories
Part D claims for Dupixent Pen by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 1,204 35,980 $139,088,545
NY 940 30,627 $120,721,762
TX 792 21,895 $88,002,207
FL 808 21,302 $85,220,393
PA 642 19,413 $75,237,905
MA 502 15,661 $61,820,696
GA 443 15,193 $60,138,119
OH 472 15,040 $58,836,173
MI 442 14,653 $56,650,079
NC 484 14,091 $55,370,341
IL 450 12,899 $51,229,779
NJ 384 10,501 $41,613,433
IN 318 9,284 $36,723,444
SC 259 9,260 $38,437,312
CT 246 8,580 $35,860,382
The other 37 states and territories
State Prescribers Claims Drug cost
TN 302 8,547 $34,292,730
AL 231 8,467 $32,678,624
LA 232 8,449 $33,441,578
KY 244 8,352 $32,794,204
VA 316 8,056 $32,121,796
WI 241 7,395 $29,362,117
WA 256 6,748 $26,944,578
CO 243 6,126 $24,450,378
AZ 255 5,934 $24,614,279
MD 230 5,907 $23,844,571
MN 217 5,786 $22,685,315
MO 215 5,725 $23,244,445
MS 120 3,804 $14,509,811
IA 132 3,751 $14,758,913
OR 147 3,581 $14,229,367
OK 120 3,344 $13,319,015
PR 70 3,064 $11,865,851
ME 71 2,671 $10,400,581
NV 89 2,611 $10,235,157
AR 92 2,606 $10,150,618
HI 63 2,579 $10,206,643
WV 82 2,496 $9,892,131
NH 86 2,493 $9,706,035
KS 100 2,226 $8,841,324
NE 84 2,186 $9,169,503
ID 61 1,854 $7,293,104
DE 40 1,547 $6,496,555
NM 54 1,502 $6,268,430
MT 40 1,483 $5,632,193
VT 39 1,334 $5,561,690
UT 75 1,300 $5,487,724
RI 53 1,209 $4,950,759
SD 44 1,087 $4,151,233
DC 26 721 $2,830,064
ND 29 713 $2,762,126
AK 15 474 $2,188,701
WY 12 181 $789,612

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 39
Part D claims for Dupixent Pen by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Dermatology 4,553 152,119 $599,989,008
Physician Assistant 2,469 74,553 $294,408,488
Pulmonary Disease 1,645 46,860 $184,084,428
Nurse Practitioner 1,551 44,370 $174,927,216
Allergy/ Immunology 1,173 33,860 $135,616,744
Otolaryngology 565 11,416 $45,225,852
Internal Medicine 380 9,429 $37,042,382
Critical Care (Intensivists) 196 5,407 $21,069,393
Student in an Organized Health Care Education/Training Program 155 3,427 $12,913,860
Family Practice 135 2,670 $10,289,693
Gastroenterology 118 1,661 $12,235,122
Micrographic Dermatologic Surgery 28 822 $3,268,378
Pediatric Medicine 33 757 $3,049,254
Interventional Pain Management 1 597 $2,247,961
Pharmacist 13 539 $2,038,157

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Melissa Knuckles Dermatology KY 808 $3,218,201 $47,118
Jerald Hurdle Interventional Pain Management ME 597 $2,247,961 $431
George Drew Dermatology OH 501 $1,956,849 $83,780
Jamiel Ramos Nurse Practitioner TX 395 $1,494,707 None on record
Janiece Feuerstein Nurse Practitioner MI 371 $1,396,824 $43

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for dupilumab

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record